33
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
October 1, 2025
Create a timeline
Public Timelines
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
FAQ
Obtenir le Premium
Close
Create a timeline
Public timelines
Library
FAQ
About & Feedback
Un accord
Confidentialité
Bibliothèque
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Télécharger
Export
Créer une copie
Premium
Intégrer dans le site Web
Share
SCLC treatment evolution
Category:
Autre
mise à jour avec succès:
4 mars 2020
0
0
245
Auteurs
Created by
Halocy
Attachments
Comments
Les événements
1942: nitrogen mustard first used [3]
1968: SCLC divided into limited disease (LD) and extensive disease (ED) stages [3]
1969: Cyclophosphamide single-agent chemotherapy shown to be effective [3]
1969: Medical Research Council: superior survival benefit with primary radical radiation therapy compared to surgery [3]
March 2019: Atezolizumab approved as first line treatment for ES-SCLC by FDA
Périodes
1959-1962 Recognition of small cell lung cancer (SCLC) as a separate category from other lung cancers [3]
1970s: Combination therapy shows dramatic responses. Fraction of patients experienced very long-term disease-free survival [3]
1980s: Combination cisplatin/etoposide with chemotherapy becomes treatment of choice [3]
1990s: Chemotherapy used for relapsed disease [4]
2000s: Development and study of new therapeutic targets for SCLC with mixed results [3]
About & Feedback
Un accord
Confidentialité
Bibliothèque
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments